Novartis Owners | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Novartis AG

Novartis AG | Ownership

Companies that own Novartis AG

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

The Vanguard Group, Inc.

59,032,432

2.31%

471,668

0.16%

07/31/2018

Norges Bank Investment Management

54,693,999

2.14%

1,810,752

0.64%

12/31/2017

Capital Research & Management Co. (Global Investors)

45,927,985

1.8%

4,262,909

0.69%

06/30/2018

UBS AG (Investment Management)

42,573,858

1.67%

1,130,835

2.7%

09/04/2018

Wellington Management Co. LLP

33,062,767

1.3%

2,652,402

0.51%

07/31/2018

BlackRock Fund Advisors

30,049,736

1.18%

47,678

0.12%

09/06/2018

Capital Research & Management Co. (World Investors)

24,176,351

0.95%

194,300

0.28%

06/30/2018

Zürcher Kantonalbank (Investment Management)

23,285,952

0.91%

289,295

5.32%

07/31/2018

Credit Suisse Asset Management (Schweiz) AG

20,771,998

0.81%

247,764

2.71%

07/31/2018

Dodge & Cox

16,370,270

0.64%

-650,300

0.71%

06/30/2018

About Novartis

View Profile

Address	Lichtstrasse 35 Basel Basel-Stadt (Basle Town) 4056 Switzerland
Employees	-
Website	http://www.novartis.com
Updated	07/08/2019
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals.